Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Dutch Biotech Company, IAVI Sign Exclusive Licensing Agreement to Develop AIDS Vaccine

September 15, 2004

Dutch biotechnology company Crucell on Tuesday announced an exclusive licensing agreement with the International AIDS Vaccine Initiative to develop an AIDS vaccine based on the company's AdVac technology, Reuters reports. Crucell likely will receive between $3.7 million and $6.1 million in advance payments as a result of the agreement, industry analyst Adrian Howd said. The company also will receive annual, milestone and royalty payments, according to a company release. Crucell's AdVac technology triggers an immune response by delivering genetic material through the common cold virus (Reuters, 9/14). According to an IAVI report released in July, more than 30 vaccines are currently in clinical trials. However, of the 30 vaccine candidates being researched in 19 countries, only one has reached the final testing phase. IAVI has called for $1.3 billion in funding for vaccine development. IAVI President and CEO Seth Berkley said that annual spending on vaccine research is about $650 million -- less than 1% of the total spending on all HIV/AIDS product development (Kaiser Daily HIV/AIDS Report, 7/13).

Back to other news for September 15, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement